Regulating Stem Cell Secretome Using Injectable Hydrogels with In Situ Network Formation
- 6 October 2016
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 5 (21) , 2758-2764
Abstract
A family of shear‐thinning hydrogels for injectable encapsulation and long‐term delivery (SHIELD) has been designed and synthesized with controlled in situ stiffening properties to regulate the stem cell secretome. The authors demonstrate that SHIELD with an intermediate stiffness (200–400 Pa) could significantly promote the angiogenic potential of human adipose‐derived stem cells.Keywords
This publication has 43 references indexed in Scilit:
- The Secretome of Alginate-Encapsulated Limbal Epithelial Stem Cells Modulates Corneal Epithelial Cell ProliferationPLOS ONE, 2013
- Clinical applications of mesenchymal stem cellsThe Korean Journal of Internal Medicine, 2013
- Improving Viability of Stem Cells During Syringe Needle Flow Through the Design of Hydrogel Cell CarriersTissue Engineering Part A, 2012
- Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular DiseaseCell Stem Cell, 2012
- A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor CellsJournal of Visualized Experiments, 2011
- Growth factor delivery-based tissue engineering: general approaches and a review of recent developmentsJournal of The Royal Society Interface, 2010
- Two-component protein-engineered physical hydrogels for cell encapsulationProceedings of the National Academy of Sciences, 2009
- Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs)Biochemical and Biophysical Research Communications, 2009
- Novel Cell-Free Strategy for Therapeutic Angiogenesis: In Vitro Generated Conditioned Medium Can Replace Progenitor Cell TransplantationPLOS ONE, 2009
- A critical analysis of current in vitro and in vivo angiogenesis assaysInternational Journal of Experimental Pathology, 2009